Increased circulation of GII.17 noroviruses, six European countries and the United States, 2023 to 2024

Euro Surveill. 2024 Sep;29(39):2400625. doi: 10.2807/1560-7917.ES.2024.29.39.2400625.

Abstract

We report an increase in GII.17 norovirus outbreaks and sporadic infections of acute gastroenteritis in Austria, Germany, France, Ireland, the Netherlands, England and the United States during the 2023/24 season. A decrease in GII.4 coincided with GII.17 prevalence increasing to between 17% and 64% of all GII detections. Overall, 84% of the GII.17 strains clustered closely with strains first reported in Romania in 2021 and two new sub-lineages were identified. Norovirus surveillance and molecular characterisation should be prioritised this winter.

Keywords: GII.17; GII.4; Norovirus; emergence; gastroenteritis.

MeSH terms

  • Caliciviridae Infections* / epidemiology
  • Caliciviridae Infections* / virology
  • Disease Outbreaks*
  • Europe / epidemiology
  • Feces / virology
  • Gastroenteritis* / epidemiology
  • Gastroenteritis* / virology
  • Genotype
  • Humans
  • Norovirus* / genetics
  • Norovirus* / isolation & purification
  • Phylogeny
  • Population Surveillance
  • Prevalence
  • RNA, Viral / genetics
  • Seasons
  • United States / epidemiology

Substances

  • RNA, Viral